Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology
The use of radial access during PCI procedures is increasing throughout the United States, and new data presented at the SCAI's annual meeting suggest that could be beneficial for patients.
FDA approves Abbott’s resorbable stent for BTK arteries
The bioresorbable stent, examined at length for the LIFE-BTK clinical trial, stays in place for up to three years before completely dissolving.
FDA clears new catheter for peripheral blood clots
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky.
Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair
How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview.

LimFlow, a medical device company with locations in California and Paris, has gained approval from the U.S. Food and Drug Administration (FDA) for its LimFlow System for Transcatheter Arterialization of Deep Veins. The LimFlow System was designed to help reestablish blood flow in chronic limb-threatening ischemia (CLTI) patients who face a high risk of amputation and have no other endovascular or surgical options available to them.

FDA approves new minimally invasive CLTI treatment for ‘no-option’ patients at risk of amputation

The new device, the first of its kind to gain FDA approval, was designed for patients who have no other endovascular or surgical options available to them.

September 12, 2023

Private equity-backed cardiology group partners with additional healthcare investment firm.

High profits, consistent growth: Shockwave Medical seen as a ‘must-buy’ stock

Shockwave and two other healthcare companies in the cardiovascular health space are considered attractive options for investors looking to expand their portfolios.

September 8, 2023

The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED).

Bleeding events after TAVR: An updated look at a serious side effect

Researchers explored data from more than 2,300 patients, categorizing all bleeding events based on updated VARC-3 definitions. The team's final analysis was published in JACC: Cardiovascular Interventions.

September 7, 2023

stroke brain dementia alzheimer's puzzle mental health

Delirium after TAVR: A common side effect linked to increased mortality

Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement.

September 5, 2023

VIDEO of Prof. Steen Kristensen explaining key trials and news from ESC 2023. #ESC #ESCcongress #ESC2023 ESCcongress2023

Key takeaways from ESC Congress 2023

Steen Dalby Kristensen, a cardiologist with Aarhus University Hospital in Denmark, detailed some of the hottest topics at the European Society of Cardiology's annual meeting.

August 31, 2023

Interventional cardiologists performing PCI

Immediate vs. staged multivessel PCI: How the 2 strategies compare when treating STEMI patients

Researchers explored data from more than 400 STEMI patients, presenting their work at ESC Congress 2023 and publishing it in the New England Journal of Medicine.

August 29, 2023

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

August 28, 2023

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold.

August 25, 2023

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Cath Lab

Radial vs. femoral access during PCI: Real-world data show proof of a ‘sea change’ in cardiology

FDA approves Abbott’s resorbable stent for BTK arteries

FDA clears new catheter for peripheral blood clots

Cardiologists make history, perform first-ever transcaval TAVR for pure aortic regurgitation

Q&A: Interventional cardiologist details key breakthroughs in tricuspid valve replacement and repair

Around the web